Navigation Links
Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced
Date:6/9/2008

PHILADELPHIA, June 9 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced today a voluntary recall of two (2) lots of the ADHD patch DAYTRANA (lots 2750211 and 2764111). Shire is taking this action because some DAYTRANA patches do not meet their release liner removal specification, and as a result, patients and caregivers could have difficulties removing the liners. This voluntary recall is not due to safety issues.

Because this voluntary recall is not due to product safety issues, all DAYTRANA patches, including those in the lots listed above, can continue to be used unless the release liner cannot be removed, or the patches are damaged while being opened.

The current supply levels of DAYTRANA should be sufficient to ensure that patients can continue to have their DAYTRANA prescriptions filled at their local pharmacy. Noven Pharmaceuticals, Inc. continues to manufacture and Shire continues to promote this product in the United States.

Shire will continue its ongoing quality assurance monitoring and data analysis of DAYTRANA, and may implement future additional voluntary actions. Shire and Noven continue to actively pursue enhancements to this product, and to work closely with the United States Food and Drug Administration (FDA) to implement changes that may enhance the usability of DAYTRANA.

Physicians, patients and caregivers who have questions regarding DAYTRANA should call Shire's DAYTRANA customer service line at 1-800-828-2088, option 1, and pharmacists should call 1-888-879-8218.

DAYTRANA is licensed globally to Shire by Noven. Shire and Noven have notified the FDA of this voluntary recall.

Notes to editors

Important Safety Information

Tell your doctor about any heart conditions, including structural abnormalities, your child or a family member may have. Inform your doctor immediately if the child develops symptoms that sugges
'/>"/>

SOURCE Shire Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
2. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
3. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
4. Application for Listing of Shire Limited Ordinary Shares
5. Limited transparency in federal nanotech research may hamper development
6. Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
7. Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R)
8. Sunrise Biotech Holding Limited Application For Admission to PLUS
9. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
10. Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
11. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Die Übersetzungen wurden von PRNewswire ... der englischen Version handelt es sich um ... Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für ... -Definition [1] als kontrolliert gelten können ... von vier Denkweisen zugeordnet werden können, die alle von ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Patheon ... manufacturing services to the global pharmaceutical industry, will host ... Novel Approaches to Testing” on Tuesday, June 4, 2013 ... pharmaceutical manufacturers are required to comply with regulations for ... practices with limited scientific underpinning and little evaluation of ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now... -- DALLAS, November 1, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... ... ... var shortURL ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
... hundreds of FDA inspectors; now it trains thousands of ... global team of FDA compliance experts, EduQuest is presenting ... training course for quality managers and regulatory specialists December ... (near I-95, Amtrak rail lines, and the Philadelphia airport). ...
Cached Biology Technology:Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 2Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 3Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 4Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 5Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 6Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 7Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 8Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 9Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 10Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 2Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 3Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 4Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 5Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 6Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 7Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 8Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 9Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 10Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 11Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 12Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information 13Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 2
(Date:5/24/2013)... grow by avoiding detection and destruction by the immune ... eliminate cancer cells; however, there are many factors that ... T cells are immune cells that function to suppress ... Journal of Clinical Investigation , researchers led by ... cells that infiltrate tumors express proteins that can be ...
(Date:5/24/2013)... from around the world today issued a stark warning ... one or two generations, the majority of the 9 ... handicap of severe pressure on fresh water, an absolutely ... This handicap will be self-inflicted and is, we believe, ... underlying problems led by mismanagement and sent a prescription ...
(Date:5/23/2013)... than 284 million tons of cargo, transit the Panama Canal ... for the Panama Canal Authority. Each time a ship passes ... from Gatun Lake, which is also a source of water ... , However, the advent of very large "super" cargo ships, ... has demanded change. The Panama Canal is being expanded to ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... NOVEMBER 16, 2009 Experts in soil science and representatives ... Congressional educational briefing, "The Essence of Earth and Wine: Terroir" ... House Office Building (Gold Room). Experts in ... -- how the balance of vineyard management and soil site ...
... Oak Ridge, Tenn., Nov. 16, 2009 -- An ... by the Department of Energy has made the "Jaguar" ... Laboratory, Jaguar is the scientific research community,s most powerful ... most difficult problems. The upgrade, funded with $19.9 million ...
... most people, you probably think chemistry is too difficult to ... any fun. But chemistry offers a magic and elegance to ... the fundamentals of digestion (as when good pizza goes bad!) ... Monty L. Fetterolf, both professional chemists and experienced educators, challenge ...
Cached Biology News:Soil experts to discuss terroir, the link between Earth, wine on Nov. 19 in DC 2Oak Ridge 'Jaguar' supercomputer is World's fastest 2Oak Ridge 'Jaguar' supercomputer is World's fastest 3Explore the science of familiar things -- and discover the 'Joy of Chemistry' 2
Carrier Serum...
The Lambda Control Kit contains lambda DNA and two 25mer primers, which can be used to amplify a 500bp fragment. The lambda DNA is purified by CsCl gradient centrifugation and organic extraction foll...
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
... Klein Taq is a derivative of ... N-terminally truncated Thermus aquaticus DNA polymerase. Expressed ... translation initiates at Met236, bypassing the 5'-3' ... The enzyme reveals a highly active and ...
Biology Products: